Mechanical ventilation (MV) is an important procedure for the treatment of patients with acute lung injury or acute respiratory distress syndrome in a clinical setting; however, MV can lead to severe complications, including ventilator-induced lung injury (VILI). Telocytes (TCs) can promote tissue repair following injury in the heart, kidneys, and other organs. The aim of this study was to investigate the role of TCs in VILI in mice and the associated mechanisms. By using in vivo studies in mice and in vitro studies in cells, we demonstrated that an airway injection of TCs can reduce the pulmonary inflammatory response and improve the lung function in mice with VILI and promote the proliferation of pulmonary vascular endothelial cells. We also demonstrated that the impact of TCs on VILI repair might partially due to vascular endothelial growth factor (VEGF) secreted by TCs upon VILI stimulation, and that VEGF could induce the proliferation of hemangioendothelioma endothelial cells (EOMA). Collectively, our results revealed novel functions of TCs in VILA repair and shed light on the complications that are caused by MV.
Introduction
Ventilator-induced lung injury (VILI) is a serious complication caused by mechanical ventilation (MV). Although various protective ventilation strategies for VILI can improve the prognosis of patients with acute respiratory distress syndrome [1] , no definite and effective clinical strategy for VILI currently exists. Telocytes (TCs) are a novel type of interstitial cells that were identified in the pancreas, digestive tract, breast, and other tissues in 2005 and was officially termed TCs in 2010 [2] . Recently, it has been reported that TCs can induce tissue regeneration and post-injury repair in both in vitro and in vivo tissues and organ models (e.g. heart and kidney) [3, 4] . However, whether TCs can alleviate VILI remains unknown. Therefore, to determine whether TCs play a similar role in promoting injury repair in VILI, we aimed to (i) elucidate the effects of TCs on VILI in mice; (ii) determine the role of TCs on in vitro EOMA damage; and (iii) to explore the associated mechanisms of TC-mediated alleviation of VILI.
Materials and Methods

Animals
The study protocols were approved by the Medical Faculty Ethics Committee of Fudan University (Shanghai, China). All experimental procedures were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Male C57BL/6 mice (22-25 g) aged 8-10 weeks were used in this study. The mice were housed in a temperature-controlled room on a 12/12 h light/dark cycle and fed with a standard Purina mouse chow diet.
Cell culture
Mouse TCs were kindly provided by the Dr Xiangdong Wang (the Central Laboratory, Zhongshan Hospital Affiliated to Fudan University, Shanghai, China). The cells were maintained in DMEM (Gibco-BRL, Gaithersburg, USA) containing 10% FBS (Gibco-BRL), 100 UI/ml penicillin + 0.1 μg/ml streptomycin (Gibco-BRL). The medium was changed regularly. When the cells grew to 80%-90% confluency, they were harvested via trypsinization and passaged at a ratio of 1:2. The EOMA cell line was purchased from Shanghai Huzhen Biotechnology Co (Shanghai, China) and cultured in DMEM containing 10% FBS. Cells were passaged and medium was changed regularly.
Conditioned medium collection
When the TCs reached 70% confluency, the medium was replaced by serum-free DMEM containing no lipopolysaccharide (LPS; Sigma, St Louis, USA) and cultured at 37°C for 12 h, and then the medium was harvested or the medium was replaced by serum-free DMEM containing 0.1 μg/ml LPS and cultured at 37°C for 2 h, followed by substitution with serum-free DMEM for further culturing for 12 h. The two kinds of medium were harvested and centrifuged to remove cell residue. The supernatant was stored at −20°C.
Cell treatment
To detect the effect of LPS on the proliferation of TCs and EOMA cells. These two types of cells were divided into five treatment groups (0, 0.01, 0.1, 1, and 10 μg/ml LPS). Each treatment condition was performed in replicates of six. The cell proliferation was detected at 24, 48, and 72 h after treatment.
To detect the effects of TC-conditioned media on the proliferation of EOMA cells following LPS treatment, the cells were divided into four treatment groups: (i) control group (treated with serumfree medium); (ii) LPS group (treated with serum-free medium containing 1 μg/ml LPS); (iii) TCs-CM group (treated with TCconditioned medium containing 1 μg/ml LPS); and (iv) TCs+LPS-CM group [treated with TCs (pre-treated with 0.1 μg/ml LPS for 2 h)-conditioned medium, containing 1 μg/ml LPS]. The cell proliferation was detected at 24, 36, and 48 h after treatment.
In vitro cell growth assay
The rate of cell proliferation was assessed using a CCK8 kit (Dojindo, Kumamoto, Japan). Approximately 2000 TCs or EOMA cells/well were seeded into a 96-well plate and incubated for 24 h. The cells were then treated with different concentrations of LPS for 24, 36, or 72 h. A volume of 10 μl CCK8 was added to each well and incubated for 2 h. The absorbance of each well was measured using a microculture plate reader (Labsystems, Vantaa, Finland) at a wavelength of 450 nm. The proliferation rate was calculated using the following equation: proliferation rate = (OD value of the treated group − OD value of the blank)/(OD value of control group − OD value the blank) × 100%.
Total RNA isolation and cDNA synthesis
To detect the effect of LPS on vascular endothelial growth factor (VEGF) mRNA expression in TCs, the TCs were seeded into a sixwell plate and treated with various concentrations of LPS (blank control and 1 μg/ml LPS) in serum-free DMEM for 24 or 48 h. The total RNA was isolated using Trizol reagent (Roche, Basel, Switzerland) according to the manufacturer's instructions. The RNA purity was determined by spectrophotometry (OD260/OD280 > 1.8). cDNA was synthesized from a total of 1 μg RNA using an ABM Synthesis kit (Vancouver, Canada). The reaction conditions were as follows: 25°C for 10 min, 42°C for 15 min, and 85°C for 5 min.
Real-time PCR analysis
Real-time PCR was performed in the Bio-Rad 1000-Series real-time PCR detection system (Hercules, USA) using the SYBR Premix Ex Taq (TaKaRa, Dalian, China). The primer sequences were as follows: F: 5′-GTTCAACGGCACAGTCAAG-3′, R: 5′-GCCAGTAGACTCC ACGACAT-3′ for GAPDH and F: 5′-GTACCTCCACCATGCC AAGT-3′, R: 5′-TCCTATGTGCTGGCTTTGGT-3′ for VEGF. The following cycling conditions were used: 95°C for 30-s pre-denaturing, 40 cycles of 95°C for 15-s denaturing, 60°C for 30-s for annealing, and 70°C for 30-s for extension. The level of target gene expression was calculated from the respective standard curves and the quantitative expression of VEGF was normalized using GAPDH as the internal control. The fold change in the relative gene expression to the control levels was determined using the standard 2
−ΔΔ
Ct method
Enzyme-linked immunosorbent assay
The supernatant of the TC culture was harvested following centrifugation at 300 g for 10 min. The concentrations of VEGF in the TC medium were measured using a commercial VEGF enzyme-linked immunosorbent assay (ELISA) kit (4 A Biotech, Beijing, China) according to the manufacturer's instructions.
Animal experiment design
Male C57BL/6 mice were randomly divided into three groups: (i) the normal control group (n = 12), which did not receive any intervention; (ii) the VILI group (n = 12), which was administered with low tidal volume (TV) MV, followed by 20 h of pretreatment with 3 mg/kg LPS via the trachea; and (iii) the TCs intervention group (n = 12), for which the VILI model was established and TCs were administered via the trachea as an intervention.
Animal treatment protocol
LPS pretreatment
Mice (n = 12) were anesthetized via an intraperitoneal injection of 1% sodium pentobarbital (80 mg/kg; Sinopharm Chemical Reagent Co. Shanghai, China). Oral tracheal intubation was performed with a 22 G intravenous indwelling, and an appropriate amount of LPS solution (<40 μl) was dripped into the indwelling needle. MV was administered 20 h later.
Mechanical ventilation
After being anesthetized with an intraperitoneal injection of 1% sodium pentobarbital (80 mg/kg), the mice were subjected to a tracheotomy and intubation, followed by connection to the experimental small animal ventilator breathing circuit (Shanghai Orcote Biotechnology Co., Shanghai, China), with the following parameters: respiratory rate, 75 times/min; TV, 6 ml/kg; suction ratio, 1:2; inhalation oxygen concentration (FiO 2 ), 21%; and 40 mg/kg pentobarbital was added to maintain anesthesia when necessary. The ventilation was completed after 4 h, and then the mice were sacrificed and samples were collected for subsequent examinations.
Intratracheal injection of TCs
Cultured mouse TCs were trypsinized, centrifuged, and resuspended in PBS. A total of 10 6 cells (20 μl) were infused into each mouse through intratracheal injection using the method described above. LPS was inhaled at the same time.
Assessment of lung injury
The level of pulmonary edema in the mice was assessed by determining the wet and dry weight ratio of the lung tissue. Alveolar membrane permeability was assessed by measuring the total protein contents in the bronchoalveolar lavage fluid (BALF). The pulmonary inflammatory response was assessed by Hematoxylin-Eosin (H & E) staining, counting the BALF white blood cells, and measuring the TNF-α, IL-6, and MIP-2 contents in the BALF. Six mice from each group were selected for measuring the weights of the whole lung tissue, and the wet and dry weight ratios were calculated. The other six mice were subjected to BALF collection, after which the lung tissues were fixed and subject to H & E staining.
Wet and dry weight ratio test
Wet and dry weight ratios were compared between different groups to estimate lung edema. The wet weight of the whole lung was determined immediately after removal. The lung was then placed in an oven at 65°C for at least 24 h, after which the dry weight was measured.
BALF collection and analysis
The chest was opened and a 22 G intravenous indwelling needle was inserted into the trachea, and 1 ml of phosphate buffer saline (PBS) was injected into the lung and aspirated to collect BALF. This process was repeated twice to obtain a total of approximately 0.6-0.8 ml BALF. A hemocytometer was used to enumerate the white blood cells in the BALF. A BCA kit (Beyotime, Beijing, China) was used to determine the total protein in the BALF, and the levels of TNF-α, IL-6, and MIP-2 in the BALF were detected using commercial ELISA kits (4 A Biotech).
H & E staining
After BALF collection, 0.4 ml of 4% paraformaldehyde (Phygene Life Sciences Co., Ltd, Fuzhou, China) was injected into the lung tissue. The fixed lung tissue was embedded in paraffin, sectioned, and stained with H & E (Beyotime, Shanghai, China) according to the manufacturer's instruction. The infiltration of inflammatory cells in the lung tissue was observed under a light microscope (Olympus H32101, Tokyo, Japan).
Statistical analysis SPSS 22.0 statistical software was used for all statistical analyses. All values were expressed as the mean ± SD, and t-test was used to determine the significance of the differences between two groups. ANOVA was used to determine the significance of the differences among several groups. A value of P < 0.05 was considered to be statistically significant.
Results
TCs significantly reduced inflammatory cell infiltration in the lung tissue of VILI mice
To investigate the effect of an intratracheal instillation TCs on the infiltration of inflammatory cells in the lung tissue of VILI mice, we examined H & E stained lung tissue of each group. Our results showed that compared with the control group (Fig. 1A,B) , there was thickening of the alveolar stroma in the VILI group, and there was increased inflammatory cell infiltration in the lung interstitial and perivascular regions (Fig. 1C,D) . The alveolar interstitial width in the lung tissue was reduced in VILI mice that received the intratracheal instillation of TCs, and the inflammatory infiltration in the pulmonary interstitial and perivascular regions was significantly lower than that exhibited in the VILI group (Fig. 1E,F) . These findings indicated that TCs could reduce the extent of inflammatory cell infiltration in lung tissues of VILI mice.
TCs decreased the number of white blood cells, cytokine production in the BALF but had no significant effect on the lung wet and dry weight ratio or BALF protein exudation in VILI mice
To further clarify the effect of TCs on pulmonary edema, alveolar membrane permeability, and the expressions of pulmonary inflammatory factors in VILI mice, we measured the wet and dry weight of the lung tissue, as well as the level of total protein, the number of white blood cells, and the expressions of three factors associated with lung inflammation, i.e. TNF-α, IL-6, and MIP-2, in the BALF. It was found that the wet and dry weight ratio of the lung tissue in the LPS + MV group or LPS + MV + TC group was higher than that of the control group (P < 0.05); however, there was no significant difference between these two groups ( Fig. 2A) , suggesting that TCs have no protective effect on lung tissue edema in VILI mice. The total protein level in the BALF of the LPS + MV group or LPS + MV + TC group was higher than that of the control group (P < 0.05); however, there was no significant difference between these two groups (Fig. 2B) , suggesting that TCs exert no protective effect on the permeability of the pulmonary membrane in VILI mice. The total number of white blood cells in the BALF of the LPS + MV + TC group was lower than that of the LPS + MV group but was still higher than that of the control group (Fig. 2C) . The ELISA results revealed that the net concentrations and the proportions of total TNF-α, IL-6, and MIP-2 in the BALF of in the LPS + MV + TC group were lower than those in the LPS + MV group; however, these levels were still higher than those of the control group (Fig. 2D-F) , suggesting that TCs could partially reverse the inflammatory response observed in VILI mice.
TCs could reverse the LPS-induced decrease of EOMA cell proliferation
VILI is associated with damage to both alveolar epithelial cells and pulmonary capillary endothelial cells. Pulmonary capillary endothelial cells play an important role in the maintenance of respiratory membrane stability and the pulmonary inflammatory response [5] . Therefore, to clarify whether TCs have a protective effect on pulmonary vascular endothelial cells in vitro, we stimulated TCs and EOMA cells with LPS and explored the effect of LPS on the proliferation of these cells. The results revealed that while the TC proliferation ratio remained unchanged after 24 h, it was increased in the groups treated with 10 μg/ml LPS after 48 h and increased in the groups treated with 1 and 10 μg/ml LPS after 72 h (P < 0.05; Fig. 3A-C) . These results indicate that LPS stimulation can promote TC proliferation, and the optimal drug concentration that can promote TC proliferation is 1 μg/ml. In addition, each concentration of LPS was found to cause a decrease in the proliferation ratio of the EOMA cells at all time points (P < 0.05; Fig. 3D-F) . Therefore, we speculated that TCs may improve the proliferation ratio of EOMA cells and attempted to treat EOMA cells with TC-conditioned media. It was found that the TC-conditioned medium was able to improve the decreased EOMA proliferation rate induced by LPS (P < 0.05; Fig. 3G-I ).
TCs promoted the proliferation of EOMA by increasing the synthesis and secretion of VEGF
To further explore the mechanism by which TCs improve the impaired proliferation ratio of EOMA cells, we detected the mRNA expression level of VEGF in TCs and measured the concentration of VEGF in the TC medium. The RT-PCR results demonstrated that the mRNA level of VEGF in the TCs was increased (P < 0.05) following stimulation with 0.1, 1, and 10 μg/ml LPS for 24 h (Fig. 4A) .
After 48 h of stimulation, the mRNA level of VEGF in the TCs was increased following treatment with only 0.1 μg/ml LPS (P < 0.05; Fig. 4B ). These results suggested that the transcription level of VEGF in TCs peaks at 24 h. The concentration of VEGF in the TC medium was measured by ELISA. The results revealed that 1 μg/ml LPS was able to increase the synthesis and secretion of VEGF in TCs at both the 24 (P < 0.05; Fig. 4C ) and 48 h (P < 0.05; Fig. 4D ).
Discussion
In the present study, we demonstrated that the intratracheal instillation of a TC suspension can reduce the inflammatory response in the lung tissue of VILI mice. In addition, TCs can partially reverse the LPS-induced decrease of proliferation ratio in pulmonary vascular endothelial cells through increasing the synthesis of VEGF in vitro. These findings provide new evidence for the potential use of TCs for the prevention or cure of VILI. As newly discovered interstitial cells, TCs have been found to be distributed in a variety of different tissues and organs [2, [6] [7] [8] . In addition, a large number of TCs also reside within the lung interstitium [9, 10] . Li et al. [4] and Zhao et al. [3] found that TCs can protect against acute renal tubular injury and myocardial infarction following in vivo transplantation. Accordingly, we hypothesized that TCs should also exert similar effects on lung tissue repair. We found that the intratracheal instillation of a TC suspension can reduce the infiltration of inflammatory cells in the lung tissue and reduce the levels of TNF-α, IL-6, and MIP-2 in the BALF of VILI mice. These findings indicate that TCs may play a protective role in the lung tissue by inhibiting the inflammatory response.
TCs are associated with immune cells and stem cells in various tissues through telopodes [11] [12] [13] [14] and form a complex 3D network [15, 16] . In addition, TCs are able to directly or indirectly communicate with surrounding cells via telopode (TP) or the release of Figure 2 . TCs can reduce the content of white blood cells, cytokine production in the BALF of VILI mice, but could not reduce the wet and dry weight ratio and the total protein in the BALF (A) The wet and dry weights of lung tissue in the LPS + MV group and LPS + MV+TCs group were higher than those in the control group. (B) The total protein concentration in the BALF of the LPS + MV group and LPS + MV+TCs group was higher than that in the control group. The number of white blood cells (C), as well as the net concentration and proportion of the total protein for tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), and macrophage inflammatory protein 2 (MIP-2) in the BALF of mice in the LPS + MV + TCs group were lower than those in the LPS + MV group; however, these values remained higher than those in the control group (D-F). *P < 0.05; **P < 0.01; ***P < 0.001. CON, control.
vesicles [17, 18] and may be involved in the regulation of the immune response and associated inflammation [19] . At the level of gene expression, the Cfp gene of TCs which regulates the autoimmune system, is overexpressed in the lung when compared with those in mesenchymal stem cells, fibroblasts, alveolar type II cells, airway epithelial cells, and lymphocytes [20] . The Rnf128 gene which regulates the synthesis of IL-2 and IL-4 is also overexpressed [20] . This indicates that TCs may be involved in the immune regulation and surveillance in the lung. Thus, it is speculated that TCs are likely to be involved in the regulation of the pulmonary inflammation and can inhibit the inflammatory response within the lungs of VILI mice by communicating with the surrounding cells via TP and the release of vesicles.
Although the mechanism of VILI has not been fully elucidated, the biological damage caused by the pulmonary inflammatory response plays an important role in its occurrence and development [21] . Airway pressure during MV can disrupt the gap junction between alveolar epithelial cells and alveolar capillary endothelial cells, leading to increased capillary permeability. A previous study has also demonstrated that damaged vascular endothelial cells can synthesize a large number of cytokines and inflammatory mediators and initiate the inflammatory cascade through relevant signaling The conditioned medium of TCs did improve the decreased EOMA proliferation rate caused by LPS. *P < 0.05; **P < 0.01; ***P < 0.001. CON, control.
pathways [22] . In addition, vascular endothelial cell injury plays an indispensable role in the development of VILI. Previous studies have shown that lung tissue remodeling caused by pulmonary barotrauma can activate the NF-κB signaling pathway, resulting in the synthesis of IL-6, IL-8, IL-1β, and TNF-α, as well as the increased production of other inflammatory factors [23, 24] . The current clinical application of protective ventilation strategies and anti-inflammatory drugs are not capable of fundamentally promoting the repair of lung injury [1] . In this study, we found that intratracheal TC intervention could alleviate the inflammatory reaction exhibited in VILI mice and provided a novel approach for the treatment of VILI.
We also found that the wet and dry weight ratio of the lung tissue and total protein content in the BALF of VILI mice did not significantly decrease following the intratracheal administration of TCs ( Fig. 2A,B) . Therefore, TC intervention cannot effectively alleviate the respiratory permeability and pulmonary edema observed in the lungs of VILI mice. VILI can lead to the injury of the endothelium and alveolar epithelium of the alveolar capillaries, resulting in damage to the respiratory membrane, pulmonary edema, and atelectasis [25] . Zheng et al. [26] have shown that several genes associated with tissue remodeling and repair are significantly upregulated in TCs. Although such findings may be attributed to the ability of TCs to repair the alveolar respiration membranes, this effect was insufficient in this study; however, the time intervals might be too short for TCs to exert a protective role. Therefore, the protective role of TCs in alveolar membrane permeability and pulmonary edema in the VILI mice was not obvious.
Pulmonary vascular endothelial cell injury plays an important role in the development of VILI; however, there has been little research on the protection of vascular endothelial cells in VILI. We used LPS to stimulate TCs and EOMA cells to establish an in vitro model of VILI and found that LPS stimulation could promote the proliferation of TCs to various degrees (Fig. 3A-C) , and decrease the proliferation of EOMA cells (Fig. 3D-F) . Moreover, we also found that TC-conditioned medium may partially reverse the decrease in proliferation ratio in EOMA cells induced by LPS (Fig. 3G-I) . Numerous studies have shown that VILI-related mechanical traction can significantly affect the expression, signal transduction, and regulation of the gap junctions in endothelial cells, leading to the injury and remodeling of the endothelial cell barrier [27] [28] [29] [30] . In addition, gap junctions in the vascular endothelial cells of the lung tissue play an important role in the promotion of blood coagulation [31] , the synthesis of inflammatory factors [32] , the formation and migration of the lumen [33] , and the regulation of endothelial cell permeability [34] . VEGF and EGF are the cytokines that primarily promote the proliferation of vascular endothelial cells, both of which can maintain vascular permeability and the normal formation of new blood vessels [35, 36] . A previous study has shown After 48 h of stimulation, the mRNA expression level of VEGF in the TCs was only increased in the group treated with 0.1 μg/ml LPS. Treatment with 1 μg/ml LPS increased the synthesis and secretion of VEGF in TCs both after 24 h (C) and 48 h (D). *P < 0.05; **P < 0.01; ***P < 0.001. CON, control.
that both CD34 and C-kit, which are the surface factors of hematopoietic stem cells, are expressed in TCs [37] . Additionally, Wang et al. [38] found that TC-conditioned medium had a protective effect on human pulmonary microvascular endothelial cells, suggesting that TCs may be involved in the angiogenesis within the lung. Therefore, we further examined the expression of VEGF in TCs and found that both the level of VEGF mRNA expression and cytokine production were increased following LPS stimulation (Fig. 4A,B) . These findings indicate that TCs can promote the proliferation of vascular endothelial cells under pathological conditions and appear to play a role in promoting the proliferation and repair of damaged blood vessels by increasing VEGF expression (Fig. 5) .
In summary, although TCs can alleviate the inflammatory response in VILI mice, the improvement of alveolar membrane permeability and pulmonary edema is not obvious. Moreover, TCs could restore the proliferation of pulmonary vascular endothelial cells in vitro, potentially via the synthesis and secretion of VEGF.
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